Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
Fiche publication
Date publication
juin 2023
Journal
Journal of translational medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FAVIER Laure
Tous les auteurs :
Nigon E, Lefeuvre-Plesse C, Martinez A, Chauleur C, Lortholary A, Favier L, Bats AS, Guille A, AdélaÏde J, Finetti P, de Casteljac V, Provansal M, Mamessier E, Bertucci F, Ray-Coquard I, Sabatier R
Lien Pubmed
Résumé
Uterine clear cell carcinomas (CCC) represent less than 5% of uterine cancers. Their biological characteristics and clinical management remain uncertain. A multicenter study to explore both clinical and molecular features of these rare tumors was conducted.
Mots clés
Clear cell carcinoma, Gene expression profiling, Genomics, Tissue micro-array, Uterine cancer
Référence
J Transl Med. 2023 06 23;21(1):408